REQUEST A DEMO
Total
USD $0.00
Search more companies

Adit Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Adit Pharma Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Adit Pharma Private Limited is based in India. The head office is in Mumbai. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on March 15, 1991. There are currently 23 (2025) people employed by Adit Pharma Private Limited. In 2025, the company reported a net sales revenue increase of 10.47%. There was a total growth of 5.1% in Adit Pharma Private Limited’s total assets over the same period. In, 2025, the company’s net profit margin increased by 2.88%.

Legal Address
34/133 Laxmi Indl Estate, New Link Road Andheri (West)
Mumbai; Maharashtra; Postal Code: 400053

Contact Details: Purchase the Adit Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Adit Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Adit Pharma Private Limited report to view the information.
Financial Auditors:
Purchase the Adit Pharma Private Limited report to view the information.
Incorporation Date:
March 15, 1991
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Adit Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
10.47%
Total Operating Revenue
10.62%
Operating Profit
13.26%
EBITDA
13.26%
Net Profit/Loss for the Period
13.26%
Total Assets
5.1%
Total Equity
4.88%
Operating Profit Margin
2.88%
Net Profit Margin
2.88%
Return on Equity (ROE)
2.75%
Quick Ratio
-12.46%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?